Replies to post #364707 on Amarin Corp Plc (AMRN)

[couldbebetter]

That is another BIG reason why Pfizer should be looking to acquire AMRN.
Imagine if Pfizer and Edding worked together on the promotion and
distribution of BOTH Lipitor and Vascepa. The potential market for
Vascepa in China is MASSIVE! Yet, I fear that it may never be optimized
without a motivated and competent BP owning AMRN. The same can be said
for Europe and the US. Given the experience Pfizer has with selling
Lipitor in China, they should be a superb position to understand what
they could do with Vascepa "if" they owned AMRN.